Selected article for: "active ingredient and liver disease"
Author: Li, Jian-yuan; Cao, Hong-yan; Liu, Ping; Cheng, Gen-hong; Sun, Ming-yu
Title: Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review
  • Cord-id: lxdbwd5n
  • Document date: 2014_5_13
    • ID: lxdbwd5n
    Snippet: Glycyrrhizic acid (GA) is a triterpene glycoside found in the roots of licorice plants (Glycyrrhiza glabra). GA is the most important active ingredient in the licorice root, and possesses a wide range of pharmacological and biological activities. GA coupled with glycyrrhetinic acid and 18-beta-glycyrrhetic acid was developed in China or Japan as an anti-inflammatory, antiviral, and antiallergic drug for liver disease. This review summarizes the current biological activities of GA and its medical
    Document: Glycyrrhizic acid (GA) is a triterpene glycoside found in the roots of licorice plants (Glycyrrhiza glabra). GA is the most important active ingredient in the licorice root, and possesses a wide range of pharmacological and biological activities. GA coupled with glycyrrhetinic acid and 18-beta-glycyrrhetic acid was developed in China or Japan as an anti-inflammatory, antiviral, and antiallergic drug for liver disease. This review summarizes the current biological activities of GA and its medical applications in liver diseases. The pharmacological actions of GA include inhibition of hepatic apoptosis and necrosis; anti-inflammatory and immune regulatory actions; antiviral effects; and antitumor effects. This paper will be a useful reference for physicians and biologists researching GA and will open the door to novel agents in drug discovery and development from Chinese herbs. With additional research, GA may be more widely used in the treatment of liver diseases or other conditions.

    Search related documents:
    Co phrase search for related documents
    • action mechanism and liver cell: 1, 2
    • activator protein and acute lung injury: 1, 2, 3, 4
    • activator signal transducer activation and acute lung injury: 1
    • activator signal transducer activation and liver cell: 1, 2
    • activator signal transducer and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • activator signal transducer and liver cell: 1, 2
    • active component and acute lung injury: 1